David DeLucia | Director, IR |
Robert Finizio | CEO & Co-Founder |
Daniel Cartwright | CFO |
Brian Bernick | Co-Founder & Chief Clinical Officer |
Sebastian Mirkin | CMO |
Annabel Samimy | Stifel |
Bill Maughan | Cowen |
Jay Olson | Oppenheimer |
Esther Rajavelu | Deutsche Bank |
Matthew Andrews | Jefferies |
Bill Tanner | Cantor Fitzgerald |
Good day, ladies and gentlemen. Thank you for joining us in the TherapeuticsMD First Quarter 2018 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's Director of Investor Relations, David DeLucia.
Good afternoon, everyone.